Skip to main content
Erschienen in: The Journal of Obstetrics and Gynecology of India 1/2016

26.02.2016 | Original Article

Homocysteine as Predictive Marker for Pregnancy-Induced Hypertension—A Comparative Study of Homocysteine Levels in Normal Versus Patients of PIH and Its Complications

verfasst von: Laxmi Maru, Monica Verma, Neha Jinsiwale

Erschienen in: The Journal of Obstetrics and Gynecology of India | Sonderheft 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Objective

To find the correlation between serum homocysteine levels, relevant laboratory investigations and complications associated with PIH.

Methods

This was a prospective study conducted over 2 years. Two hundred and fourteen cases were studied. They were divided into mild preeclampsia (64), severe preeclampsia (50), eclampsia (32) and control groups (68). Parameters evaluated for statistical analysis were blood pressure, platelet counts, SGOT, SGPT and serum homocysteine levels.

Results

A definite statistical correlation was found between the homocysteine levels and severity of hypertension (8 mmol/l, p = .759). A higher level of homocysteine was also associated with many maternal complications like abruption, retinopathy, MODS, maternal mortality and eclampsia. Sixty-nine out of 87 patients with elevated homocysteine levels were complicated with some or the other condition, making a high percentage of 79.31 %. Patients with normal level of homocysteine delivered healthy babies (88.1 %). There were 6 maternal mortalities and 20 stillbirths in the hyperhomocysteinemia group.

Conclusion

Homocysteine levels have a direct statistical correlation with the severity of hypertension and complication with preeclampsia and eclampsia. It can be considered as a reliable predictive marker for PIH and its wide syndrome.
Literatur
1.
Zurück zum Zitat data.worldbank.org/indicator/SH.STA.MMRT. data.worldbank.org/indicator/SH.STA.MMRT.
2.
Zurück zum Zitat Rajkovic A, Catalano PM, Malinow MR. Elevated homocysteine level with pre eclampsia. Obstet Gynecol. 1997;90:168–71.CrossRefPubMed Rajkovic A, Catalano PM, Malinow MR. Elevated homocysteine level with pre eclampsia. Obstet Gynecol. 1997;90:168–71.CrossRefPubMed
3.
Zurück zum Zitat Zeeman GG, Alexander JM, Mclntire DD, et al. Homocysteine plasma concentration levels for the prediction of pre eclampsia in women with chronic hypertension. Am J Obstet Gynecol. 2003;189:574–6.CrossRefPubMed Zeeman GG, Alexander JM, Mclntire DD, et al. Homocysteine plasma concentration levels for the prediction of pre eclampsia in women with chronic hypertension. Am J Obstet Gynecol. 2003;189:574–6.CrossRefPubMed
4.
Zurück zum Zitat Levine RJ, Maynard SE, Gian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672–83.CrossRefPubMed Levine RJ, Maynard SE, Gian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672–83.CrossRefPubMed
5.
Zurück zum Zitat Dekker AG, DeVries JIP, Doelitzach PM, et al. Underlying disorders associated with severe early onset preeclampsia. Am J Obstet Gynecol. 1995;173:1042–8.CrossRefPubMed Dekker AG, DeVries JIP, Doelitzach PM, et al. Underlying disorders associated with severe early onset preeclampsia. Am J Obstet Gynecol. 1995;173:1042–8.CrossRefPubMed
6.
Zurück zum Zitat Sunita G, Sheela J, Bhavna K, et al. A study of serum homocysteine levels during normal pregnancy and pre eclampsia. J South Asian Fed Obstet Gynaecol. 2011;3(2):71–4. Sunita G, Sheela J, Bhavna K, et al. A study of serum homocysteine levels during normal pregnancy and pre eclampsia. J South Asian Fed Obstet Gynaecol. 2011;3(2):71–4.
7.
Zurück zum Zitat Laskowska M, Oleszczuk J. Homocysteine in pregnancies complicated by preeclampsia with and without IUGR: a comparison with normotensive pregnant women with isolated IUGR and healthy pregnant women. Open J Obstet Gynaecol. 2011;1:191–6.CrossRef Laskowska M, Oleszczuk J. Homocysteine in pregnancies complicated by preeclampsia with and without IUGR: a comparison with normotensive pregnant women with isolated IUGR and healthy pregnant women. Open J Obstet Gynaecol. 2011;1:191–6.CrossRef
8.
Zurück zum Zitat Erdemoğlu E, Uğur M, Erdemoğlu E. Plasma homocysteine and nitric oxide levels in preeclampsia. J Turk Ger Gynaecol Assoc. 2009;10:26–9. Erdemoğlu E, Uğur M, Erdemoğlu E. Plasma homocysteine and nitric oxide levels in preeclampsia. J Turk Ger Gynaecol Assoc. 2009;10:26–9.
9.
10.
Zurück zum Zitat D’Anna R, Baviera G, Corrado F, et al. Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction. Acta Obstet Gynecol Scand. 2004;83:155–8.CrossRefPubMed D’Anna R, Baviera G, Corrado F, et al. Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction. Acta Obstet Gynecol Scand. 2004;83:155–8.CrossRefPubMed
11.
Zurück zum Zitat Ray JG, Laskin CA. Folic acid and homocysteine metabolic defects and the risk of placental abruption, preeclampsia and spontaneous pregnancy loss: a systematic review. Placenta. 1999;20:519–29.CrossRefPubMed Ray JG, Laskin CA. Folic acid and homocysteine metabolic defects and the risk of placental abruption, preeclampsia and spontaneous pregnancy loss: a systematic review. Placenta. 1999;20:519–29.CrossRefPubMed
12.
Zurück zum Zitat Kerkeni M, Addad F, Chauffert M, et al. Hyperhomocysteinemia, endothelial nitric oxide synthase polymorphism, and risk of coronary artery disease. Clin Chem. 2006;52:153–8.CrossRef Kerkeni M, Addad F, Chauffert M, et al. Hyperhomocysteinemia, endothelial nitric oxide synthase polymorphism, and risk of coronary artery disease. Clin Chem. 2006;52:153–8.CrossRef
13.
Zurück zum Zitat Var A, Yıldırım Y, Onur E, et al. Endothelial dysfunction in preeclampsia. Increased homocysteine and decreased nitric oxide levels. Gynecol Obstet Invest. 2003;56:221–4.CrossRefPubMed Var A, Yıldırım Y, Onur E, et al. Endothelial dysfunction in preeclampsia. Increased homocysteine and decreased nitric oxide levels. Gynecol Obstet Invest. 2003;56:221–4.CrossRefPubMed
14.
Zurück zum Zitat Lindblad B, Zaman S, Malik A, et al. Folate, vitamin B12 and homocysteine levels in South Asian women with growth-retarded fetuses. Acta Obstet Gynecol Scand. 2005;84:1055–61.PubMed Lindblad B, Zaman S, Malik A, et al. Folate, vitamin B12 and homocysteine levels in South Asian women with growth-retarded fetuses. Acta Obstet Gynecol Scand. 2005;84:1055–61.PubMed
15.
Zurück zum Zitat Hogg CD, Harirah H, Basherra H, et al. Serum soluble Fas levels in preeclampsia. Obstet Gynecol. 2001;97:530–2. Hogg CD, Harirah H, Basherra H, et al. Serum soluble Fas levels in preeclampsia. Obstet Gynecol. 2001;97:530–2.
Metadaten
Titel
Homocysteine as Predictive Marker for Pregnancy-Induced Hypertension—A Comparative Study of Homocysteine Levels in Normal Versus Patients of PIH and Its Complications
verfasst von
Laxmi Maru
Monica Verma
Neha Jinsiwale
Publikationsdatum
26.02.2016
Verlag
Springer India
Erschienen in
The Journal of Obstetrics and Gynecology of India / Ausgabe Sonderheft 1/2016
Print ISSN: 0971-9202
Elektronische ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-015-0832-4

Weitere Artikel der Sonderheft 1/2016

The Journal of Obstetrics and Gynecology of India 1/2016 Zur Ausgabe

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Menopausale Hormontherapie für Frauen über 65?

07.05.2024 Klimakterium und Menopause Nachrichten

In den USA erhalten nicht wenige Frauen auch noch im Alter über 65 eine menopausale Hormontherapie. Welche positiven und negativen gesundheitlichen Konsequenzen daraus möglicherweise resultieren, wurde anhand von Versicherungsdaten analysiert.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.